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A investigação química do extrato bruto de uma ascidia do gênero Didemnum levou ao 
isolamento das dicetopiperazinas modificadas rodriguesinas A (1) e B (2) na forma de uma mistura 
de homólogos, os quais puderam ser identificados pela análise de seus dados espectroscópicos 
inclusive experimentos MS/MS. A investigação de uma segunda ascídia do gênero Didemnum 
forneceu a N-acetil-rodriguesina A (3) e a N-acetil-rodriguesina B (4). A configuração absoluta 
dos compostos 1 e 2 pode ser estabelecida por hidrólise e análise de Marfey e por comparação 
com dados da literatura do composto 3, previamente obtido como produto de síntese. A mistura 
de 1 e 2 apresentou atividade antibiótica moderada contra um isolado clínico de Streptococcus 
mutans, contra S. mutans UA159 e S. aureus ATCC6538.
The chemical investigation of the crude extract of an ascidian of the genus Didemnum led to the 
isolation of the modified diketopiperazine rodriguesines A (1) and (2) as a mixture of homologues, 
which could be identified by analysis of spectroscopic data including MS/MS experiments. The 
investigation of a second Didemnum sp. led to the isolation of N-acetyl-rodriguesine A (3) and 
N-acetyl-rodriguesine B (4). The absolute configuration of compounds 1 and 2 could be established 
by hydrolysis and Marfey’s analysis and comparison with literature data reported for compound 3, 
previously obtained as a synthetic product. The mixture of 1 and 2 displayed moderate antibiotic 
activity against a clinical isolate of Streptococcus mutans and against S. mutans UA159 and 
Staphylococcus aureus ATCC6538.
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Introduction
Ascidians, or sea-squirts, are cosmopolitan, exclusively 
marine invertebrates, which constitute a rich source of 
biologically active secondary metabolites.1 It has been 
estimated that ca. 85% of ascidian natural products are 
derived from amino acids, while the remaining 15% are 
derived from polyketide and/or terpenoid pathways.2 
Ascidians of the family Didemnidae are recognized as 
a particularly unique source of modified peptides and 
alkaloids.3 These include the well known tamandarins,4 
didemnins, aplidine and related compounds,5 which 
display potent antitumor and immunosupressive activities, 
as well as many bioactive alkaloids such as the G2 
cell cycle checkpoint inhibitors granulatimide and 
isogranulatimide.6
During several years we have collected distinct species 
of colonial didemnidae ascidians, in order to expand the 
diversity of our library of crude extracts.7 These animals 
are not easy to collect, since they frequently present 
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encrusting, thin and soft bodied colonies. Two such 
species were collected during 1999, as red Didemnum spp. 
The two Didemnidae species gave crude extracts which 
displayed antituberculosis and cytotoxic activities. The 
investigation of these extracts led to the isolation of four 
modified diketopiperazines, which are the subject of the 
present report.
Results and Discussion
The  hexane-defated MeOH extract of the ascidian 
Didemnum sp. (sample BA99ASCI-05) presented 
aromatic, nitrogen-bearing derivatives indicated by 
TLC and 1H NMR analyses. The MeOH extract was 
separated by chromatography on Sephadex LH-20 and C18 
reversed-phase columns. Further HPLC separations using 
C18-phenyl or cyanopropyl silica columns did not provide 
rodriguesines A (1) and B (2) as pure compounds, even 
using TFA, NH4Cl or phosphoric acid buffers in the eluents. 
Subsequent analysis of 2D NMR and MS/MS analysis 
indicated that rodriguesines A (1) and B (2) were obtained 
as an inseparable mixture from the Didemnum sp. sample 
BA99ASCI-05.
NMR analysis of the fraction containing 1 and 2 
indicated the presence of a phenylalanine residue (d Hα 
4.27, d CH2-β 3.05 and 3.20, d aromatic Hs 7.24-7.36), a 
glycine residue (d 3.08 and two doublets at d 3.55/3.56), 
a linear alkyl β-amino acid and a mono-acylated diamine 
moiety. These structural features were evident by analysis 
of the HSQC, COSY and HMBC spectra, of which key 
correlations are shown in Figure 1. The linear alkyl 
β-amino acid moiety was assigned from the carbonyl 
substituted methylene CH2-18 (d 2.27 and 2.38) coupled 
in the COSY spectrum to the broad methine signal at d 
4.65, itself correlated with a methylene group at d 1.55 and 
1.59 (CH2-20) substituted with the alkyl chain (multiplet 
at d 1.30). The diamino moiety was assigned from the 
amino-substituted methylene at d 2.97 (CH2-14) which 
showed couplings with methylene signals at d 1.87 and d 
1.69. This methylene (CH2-15 in 1)”. showed a correlation 
with a methylene group at d 3.31 and 3.28 (CH2-16), while 
the methylene at d 1.69 (CH2-15 in 2) was coupled to a 
methylene group at d 1.55 (CH2-15a in 2), itself attached to 
a methylene at d 3.23 (CH2-16 in 2). Correlations between 
the methylene at d 3.28 and 3.31 (CH2-16), as well as the 
methylene CH2-18 (d 2.27 and 2.38), with the carbonyl 
groups at d 172.9 and 173.6 established the connectivity 
between the diamino moiety and the β-amino acid residue. 
Couplings between H-3 and C-2 (d 168.5/168.4) and C-5 
(d 168.6/168.4), as well as between CH2-6 with the same 
carbonyl carbons, allowed us to assign the piperazine-2,5-
dione moiety. The junction between the diketopiperazine 
residue with the β-amino acid moiety was established by a 
correlation observed between the glycyl doublet hydrogens 
of 1 and 2 at d 3.55/3.56 with C-19.
Considering the planar structures assigned for 1 and 
2, a search in MarinLit and SciFinder led us to discover 
that these compounds were closely related to etzionin (5), 
Figure 1. Structural fragments observed for 1 and 2.
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previously isolated from the ascidian Didemnum rodriguesi. 
However, the spectroscopic data of etzionin was not very 
informative, since only broad, poorly-defined NMR signals 
have been reported for 5.8 A distinctive feature between 1 
and 2 and etzionin (5) was that no evidence was obtained 
in the infrared spectrum of 1 and 2 for the presence of the 
unusual etzionin hydroxamate group. We observed only 
a broad νN-H band at 3283 cm-1 but not a band associated 
with a νO-H at higher wavenumbers. Additionally, since the 
analysis of the acyl monosubstituted diamino moiety in 
the mixture of 1 and 2 indicated the presence of two amide 
carbonyls and two diamine alkyl chains, we suspected that 
two diamine homologues constituted the fraction isolated 
from the Didemnum sp. BA99ASCI-05. Indeed, analysis 
by HRMS/MS showed that the fraction containing 1 and 
2 displayed two quasi-molecular ions [M+H]+ at m/z 
459.3335 (C26H43N4O3) and m/z 473.3492 (C27H45N4O3), 
which, upon fragmentation, gave an identical fragment ion 
at m/z 385.2500 (C23H33N2O3) corresponding to the lost of 
C3H10N2 (1,3-diaminopropane) from 1 and of C4H12N2 (1,4-
diaminobutane) from 2 (Figure 2). The analysis of the MS/MS 
spectrum also indicated the formation of the corresponding 
oxazepine and oxazine ions at m/z 238.2181 and 252.2352, 
respectively, as well as the formation of a diketopiperazinium 
at m/z 343.2416 (Figure 2). Therefore, the complete planar 
structure of rodriguesine A (1) and B (2) was confirmed. 
Further support for the structures assigned for both 1 and 
2 could be obtained after acetylation of this mixture and 
separation by HPLC. This procedure gave compounds 3 and 
4 (see below) of which compound 3 showed NMR data very 
similar to that of bis-acetyl etzionin (6).8
In order to establish the absolute configuration of 
the phenylalanine residue, the mixture of 1 and 2 was 
subjected to hydrolysis followed by derivatization with 
Marfey’s reagent (1-fluoro-2,4-dinitrophenyl-5-l-alanine 
amide) and LC-PDA-MS analysis. Only l-phenylalanine 
was detected. Moreover, since the absolute configuration 
of etzionin (5) was established after the total synthesis 
of its 4-desoxy-N-acetyl derivative (3),9 we decided to 
acetylate the mixture of 1 and 2 in order to separate both 
N-acetyl derivatives and compare the specific rotation of 
4-desoxy-N-acetyl etzionine (3) derived from 1 with the 
literature value reported for synthetic 3. The acetylated 
mixture of 3 and 4 could be separated by C18 HPLC. 
Compound 3, obtained after acetylation of 1, showed 
[α]D−37.0 (c 0.026, CHCl3), very close to the value reported 
for synthetic (-)-(3S,19R)-3, [α]D −53.1 (c 0.06, CHCl3). 
The 1H NMR spectrum of 3 obtained from the acetylation 
of 1 was identical to that of synthetic (-)-(3S,19R)-3.9 Since 
the absolute configuration of the phenylalanine residue in 3 
Figure 2. Major fragment ions observed in the MS/MS spectrum of 1 and 2.
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derived from the acetylation of natural 1 is S, the absolute 
configuration of C-19 must be R. After acetylation and 
purification, compound 4 obtained from 2 showed [α]D −52 
(c 0.04, CHCl3). Therefore, both rodriguesines A (1) and B 
(2) have the 3S, 19R absolute configuration. 
Sample BA99ASCI-03 of the second Didemnum species 
gave, after a similar isolation procedure, small quantities of 
3 and 4 as pure compounds. Analysis of the spectroscopic 
data recorded for N-acetyl rodriguesine A (3) clearly assigned 
the presence of an acetyl group (C=O at dC 173.4; CH3 at dC 
22.7 and dH 1.92), corroborated by the HRESIMS analysis 
which showed a [M+H]+ quasi-molecular ion at m/z 501.3483 
(C28H45N4O4), indicating an additional C2H2O fragment 
compared to the formula of 1. Analysis of the NMR data 
of the diamino moiety in 3 showed a coupling between the 
methylenes at d 3.18 (t, 8.4 Hz, 6H, CH2-14 and CH2-16) 
and two carbonyl groups at dC 173.4 and 172.7. Since the 
methylene CH2-18 (d 2.20 and 2.32) confirmed a long-range 
coupling with the carbonyl group at dc 172.7 (C-17), and 
the methyl acetyl group showed a long range coupling with 
the carbonyl at dC 173.4, the acetyl group could be placed 
at the diamine terminus of compound 3. Analogous MS 
and NMR data recorded for N-acetyl rodriguesine B (4) 
showed a quasi-molecular ion [M+H]+ at m/z 515.3639 
(C29H47N4O4) and quite similar NMR data for the diamide 
moiety (Tables 1 and 2), except for the presence of an 
additional methylene group (CH2-15a at dH 1.50 and dC 
27.8) in the diamino moiety. Comparison of 1H, 13C NMR 
and MS data recorded for natural 3 and 4 with data recorded 
for 3 and 4 derived from the acetylation of 1 and 2 proved 
them to be identical compounds. Therefore, the structure of 
the natural, minor N-acetylated compounds 3 and 4, could 
be established. Compounds 3 and 4 should have the same 
absolute configuration as compounds 1 and 2 since their [α]D, 
HPLC tR, 1H and MS data are practically identical to 3 and 4 
obtained from the acetylation of the mixture of 1 and 2.
The mixture of 1 and 2 was evaluated in cytotoxic, 
antituberculosis and antibiotic bioassays against a panel of 
pathogenic bacteria. Surprisingly, rodriguesines A 1 and B 
2 did not present cytotoxic or antituberculosis activities. 
The mixture of 1 and 2 was weakly active against the 
majority of the pathogen microbial strains tested (Table 
3), except against Pseudomonas aeruginosa P1 (MIC 
at 4.3 µg mL-1), obtained from a hospital environment. 
Interestingly, the mixture of 1 and 2 proved to be more 
active against antibiotic-resistant strains than against 
standard ATCC or NTCC strains (Table 3). The strains 
Streptococcus mutans clinical isolate 2.M7/4, S. mutans 
UA159, Staphylococcus aureus ATCC6538, Escherichia 
coli NTCC861, Enterococcus faecalis ATCC14506, 
Streptococcus sanguinis ATCC15300, S. sobrinus 
ATCC27607 and Candida albicans ATCC36801(serum 
type A) are all associated with muco-bucal diseases.
Conclusion 
We reported here the isolation of four new modified 
diketopiperazines from two ascidians of the genus 
Didemnum. The mixture of 1 and 2 displayed moderate 
antibiotic activity against several human pathogenic 
bacteria. 
Experimental
General experimental procedures
Optical rotations were measured on a Perkin Elmer 
341 MC polarimeter at 20 oC. IR spectra (film on Si 
plate) were recorded on a FT-IR Bomem MB102 infrared 
Table 1. 1H  data for compounds 1 and 2, 3 and 4 in CD3OD at 400 MHz 
[d, multiplicity (J in Hz)]
Position  1 and 2  3  4
3 4.27 (t, 5.0) 4.27 (t, 6) 4.22 (t, 6.5)
6
3.08 (d, 17), 
3.55/3.56 
(2d, 17 Hz each)
3.00 (d, 22), 
3.50 (d, 22)
2.99 (d, 22), 
3.50 (d, 22)
7 3.05 (m), 3.20 (m) 3.02 (dd, 5, 17), 3.16 (m)
3.01 (dd, 5, 17), 
3.16 (m)
9/13 7.24 (m) 7.21 (m) 7.20 (m)
10/12 7.36 (m) 7.31 (m) 7.28 (m)
11 7.35 (m) 7.30 (m) 7.24 (m)
14 2.97 (t, 7) 3.18 (t, 8.4) 3.16 (m)
15 1.87 (qui, 7) and 1.69 (m) 1.65 (qui, 8.4) 1.50 (m)
15a 1.55 (m) - 1.50 (m) 
16 3.28 and 3.31/3.23 3.18 (t, 8.4) 3.16 (m)
18 2.27 (dd, 7, 12), 2.38 (m)
2.20 (dd, 9, 17), 
2.32 (dd, 9, 17)
2.18 (dd, 9, 17), 
2.32 (dd, 9, 17)
19 4.65 (br) 4.60 (br) 4.57 (br)
20 1.55 (m), 1.59 (m) 1.52 (m) 1.53 (m)
21 1.18 (m) 1.14 (m) 1.14 (m)
22 1.30 (m) 1.26 (m) 1.26 (m)
23 1.30 (m) 1.26 (m) 1.26 (m)
24 1.30 (m) 1.26 (m) 1.26 (m)
25 1.30 (m) 1.26 (m) 1.26 (m)
26 1.30 (m) 1.26 (m) 1.26 (m)
27 1.30 (m) 1.28 (m) 1.28 (m)
28 0.93 (t, 7) 0.89 (t, 9) 0.89 (t, 8)
COMe - 1.92 (s) 1.91 (s)
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spectrometer. The NMR spectra were recorded on a Bruker 
ARX 9.4 T instrument, operating at 400.35 MHz for 1H and 
100.10 MHz for 13C, respectively.  All NMR spectra were 
obtained at 25 oC using TMS as an internal reference. 
Solvents used for extraction and column chromatography 
were glass distilled prior to use. HPLC-grade solvents were 
utilized without further purification in HPLC separations. 
TLC analyses were performed with precoated TLC sheets 
of Si gel on polyester, eluting with different mixtures of 
MeOH in CH2Cl2. Plates were observed under a UV lamp 
(λ
max
 254 and 365 nm). Semi-preparative HPLC separations 
were performed with a Waters 600 quaternary pump and a 
double beam model 2487 UV detector monitored by Waters 
Millenium 32. High resolution mass spectra obtained for 
1 and 2 were recorded on a Micromass Q-ToF Micro, in 
ES+ mode, using the following experimental conditions: 
capillary voltage  3.0 kV; sample cone 42.0 V; sample 
infused at 10 µL min-1 in 1: 1 MeOH/H2O. Accurate mass 
measurements were made using leucine enkephalin as 
an internal reference at [M+H]+ 556.2771. The MS/MS 
experiments were recorded using with a range of collision 
energies from 20 to 30 eV. High resolution mass spectra 
obtained for compounds 3 and 4 were recorded on a 
Bruker Daltonics equipment (UltrO-ToF, MA, USA). 
Samples (0.5 µg mL-1) dissolved in MeOH/H2O 1:1 were 
introduced in the electrospray source at 5 µL min-1 with 
a direct infusion pump.  MS/MS and MSn experiments 
were performed using standard isolation and excitation 
procedures. Nitrogen was used as nebulising and collision 
gas with the collision energy set at 4 eV. An accurate-mass 
calibration was obtained with a post acquisition application 
of a calibration created from the MS/MS of monensin A 
[M-18+Na]+ under the same CID and cell conditions. The 
collision energy was adjusted until the intensity of the 
parent ion was set between 5 and 20% relative to the base 
peak. Capillary voltage was set to 3500 V.
Animal material
The ascidians Didemnum sp. BA99ASCI-03 and 
Didemnum sp. BA99ASCI-05 were collected in August/
September 1999, from the Baía de Todos os Santos, 
Salvador, Bahia state, Brazil and immediately frozen. Both 
samples were deposited in the ascidian collection of the 
Departamento de Zoologia, Setor de Ciências Biológicas, 
Table 2. 13C data for compounds 1 and 2, 3 and 4 in CD3OD at 100 
MHz
Position 1 and 2 3 4
2 168.5/168.4 168.5 168.4
3 58.4 58.2 58.2
5 168.6/168.4 168.5 168.4
6 46.4 (br) 46.0 46.3
7 41.1/41.2 41.1 41.0
8 137.12/137.10 136.9 136.8
9/13 130.0 131.4 131.4
10/12 128.6 129.8 129.8
11 128.4 128.5 128.5
14 38.5/40.5 38.0 40.1
15 28.9/26.1 30.2 27.8
15a 27.6 - 27.8
16 37.2/39.8 38.0 40.1
17 172.9/173.6 172.7 172.5
18 39.5a/39.7a 39.6 39.6
19 53.8 (br) 54.1 54.1
20 31.8 31.5 31.6
21 27.3 27.1 27.1
22 27.6 30.7 30.2
23 30.8 30.3 30.4
24 30.6 30.5 30.5
25 30.4 30.6 30.6
26 33.3 33.1 33.0
27 23.9 23.8 23.7
28 14.7 14.5 14.4
CO - 173.4 174.0
Me - 22.7 22.6
a
 Interchangeable assignments.
Table 3. Antimicrobial activity of 1 and 2 (MIC in µg mL-1)
Pathogenic microbial strain mixture of 1 and 2
Staphylococcus aureus ATCC6538 62.5
Staphylococcus aureus ATCC259223 22.6
ORSA 8 45.3
ORSA 108 91.0
Escherichia coli ATCCNTCC861 125.0
Escherichia coli ATCC259222 45.6
Pseudomonas aeruginosa ATCC27853 22.6
Pseudomonas aeruginosa 13 45.3
Pseudomonas aeruginosa P1 4.3
Candida albicans ATCC10231 n.a.
Candida albicans ATCC36801 (serum type A) 125.0
Enterococcus faecalis ATCC14506 125.0
Streptococcus sanguinis ATCC15300 125.0
Streptococcus sobrinus ATCC27607 125.0
Streptococcus mutans UA159 62.5
Streptococcus mutans (clinical isolate 2.M7/4) 31.2
ORSA: Oxacillin-resistant Staphylococcus aureus; n.a.: not assigned.
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Universidade Federal do Paraná.  BA99ASCI-03: (DZUP 
DID 210) - colony is reddish orange when alive, but looses 
the color in formalin, zooids with the sperm duct forming 
ten coils around the only follicle of the testis, larval trunk 
oval, 0.5 mm long with four ectodermal ampullae in each 
side, long and close to each other. The three adhesive 
papillae are close to each other and present a short stalk.
BA99ASCI-05 (DZUP DID 209) - colony is red when 
alive, but looses the color in formalin, zooids with sperm 
duct forming seven coils around the only follicle of the 
testis, larval trunk 0.4 mm long with four to five ectodermal 
ampullae in each side, shorter than the ones observed in 
former voucher.  The three adhesive papillae have long 
stalks.
Extraction and isolation
The frozen ascidian sample BA99ASCI-05 (308.9 g, 
wet) was freeze dried and exhaustively extracted with 
MeOH. The MeOH extract was filtered, concentrated to 
400 mL and partitioned with hexane (3 × 400 mL). TLC 
analysis (UV and Dragendorff) of the MeOH fraction 
indicated the presence of intense UV-absorbing compounds 
with amine groups. This fraction was evaporated to 
dryness (5.6 g) before separation by C18 reversed-phase 
chromatography (gradient of MeOH in H2O) in 0.5-1.0 g 
portions. This separation yielded eleven fractions (Da-
MSP-1 to Da-MSP-11), of which the eighth (Da-MSP-8, 
1.87 g) presented most of the Dragendorff and UV positive 
compounds. The fraction Da-MSP-8 was then subjected 
to chromatography on Sephadex LH-20 (MeOH). Seven 
fractions were obtained (Da-MSP-8A to DA-MSP-8G), of 
which Da-MSP-8D (0.402 g) and Da-MSP-8E (0.532 g) 
presented aromatic nitrogen-bearing compounds. Both 
fractions were similarly purified, firstly by C18 reversed-
phase column chromatography (gradient of MeOH in H2O) 
then by HPLC (phenyl-bonded silica gel, Waters µBondapak 
10 µm,  125 Å, 7.8 × 300 mm; eluent: 65:35 MeOH/0.1% 
TFA in H2O; λmax 220 nm; flow rate: 1 mL min-1; 
tR 25.6 min) to give 0.148 g of the mixture of 1 and 2 
(0.05%, wet).
The frozen ascidian sample BA99ASCI-03 (450.0 g) was 
freeze dried and exhaustively extracted with MeOH. The 
MeOH extract was concentrated to 400 mL and partitioned 
with hexane (3 × 400 mL). The alcoholic fraction was 
evaporated until an aqueous suspension was obtained. The 
H2O fraction was first partitioned with EtOAc then with 
3:2 CH2Cl2/MeOH. The CH2Cl2/MeOH fraction (2.0 g) 
was separated by chromatography on Sephadex LH20 
(MeOH), to give five fractions (BA99AC-3A to BA99AC-
3E). The last fraction obtained (Ba99AC-3E, 214 mg) was 
subjected to chromatography on a cyanopropyl-bonded 
silica cartridge (5 g), with a gradient of EtOAc in CH2Cl2. 
The first fraction obtained from this separation (BA99AC-
3E1, 134 mg) was separated by chromatography on a silica-
gel cartridge (2 g) with a gradient of MeOH in CH2Cl2, to 
give three fractions (Ba99AC-3E1A to BA99AC-3E1C). 
The second one (BA99AC-3E1B, 38.0 mg) was separated 
by HPLC using a phenyl-bonded silica column (Inertsil, 
250 × 4.6 mm, 5 µm) using 45:55 MeCN/H2O as eluent, 
to give five fractions. Fractions BA99AC-3E1C2 (7.1 mg) 
and BA99AC-3E1C2 (4.6 mg) were purified using a C18 
reversed phase HPLC column (Phenomenex 5 µm), using 
1:1 MeOH/0.1% HCO2H in H2O as eluent, to give N-acetyl-
rodriguesine A (3, tR = 19.8 min, 3.6 mg, 8.0×10-4%) 
and N-acetyl-rodriguesine B (4, tR = 21.2 min, 4.6 mg, 
1.0×10-3%).
Rodriguesines A (1) and B (2)
Colorless, glassy solid; UV (MeOH) λ
max
 258 nm; 
1H NMR (CD3OD, 400 MHz), see Table 1; 13C NMR 
(CD3OD, 100 MHz), see Table 2; Positive HRESIMS 
for 1 m/z 459.3341 [M+H]+, calc. for C26H43N4O3 
459.3335. Positive HRESIMS for 2 473.3499 [M+H]+ 
calc. for C27H45N4O3 473.3492. MS/MS experiments: 
m/z 385.2500, corresponding to C23H33N2O3 (calc. 
385.24912); m/z 238.2181, corresponding to C15H28NO 
(calc. 238.21654); m/z 252.2352, corresponding to 
C16H30NO (calc. 252.23219); m/z 343.2416, corresponding 
to C21H31N2O2 (calc. 343.23800).
N-acetyl-rodriguesine A (3)
Colorless, glassy solid; [α]D −37 (c 0.026, CHCl3); 
UV (MeOH) λ
max
 256 nm; 1H NMR (CD3OD, 400 MHz), 
see Table 1; 13C NMR (CD3OD, 100 MHz), see Table 2; 
Positive CID-MS/MS for 1 m/z 501.3483 [M+H]+, calc. for 
C28H44N4O4 501.34408.
N-Acetyl-rodriguesine B (4)
Colorless, glassy solid; [α]D −52 (c 0.04, CHCl3); 
UV (MeOH) λ
max
 257 nm; 1H NMR (CD3OD, 400 MHz), 
see Table 1; 13C NMR (CD3OD, 100 MHz), see Table 2; 
Positive CID-MS/MS for 1 m/z 515.3639 [M+H]+, calc. for 
C29H47N4O4 515.35918.
Acetylation of rodriguesines A (1) and B (2)
The mixture of compounds 1 and 2 (40 mg) was 
stirred overnight with 1 mL of pyridine and 1 mL of acetic 
anhydride, at room temperature. The reaction medium was 
transferred to a round bottom flask and evaporated until 
dryness. The acetylated mixture was separated by C18 
Antibacterial Modified Diketopiperazines from two Ascidians of the Genus Didemnum J. Braz. Chem. Soc.710
reversed-phase HPLC (Inertsil, ODS 3 250 × 4.6 mm, 5 µm) 
with a linear gradient of MeCN in H2O, from 7:3 to 95:5 
during 30 min, to give 1.7 mg of pure N-acetyl-rodriguesine 
A (3) and 3.0 mg of pure N-acetyl-rodriguesine B (4), as 
well as 30.7 mg of an intermediate fraction containing both 
3 and 4. N-acetyl-rodriguesine A (3) showed [α]D -37.0 
(c 0.026, CHCl3) and 1H NMR, HPLC retention time and 
MS analysis identical to natural 3. Similarly, N-acetyl-
rodriguesine B (4) showed [α]D −58 (c 0.03, CHCl3) and 
1H NMR, HPLC retention time and MS analysis identical 
to natural 4.
Hydrolysis and Marfey’s analysis of rodriguesines A (1) 
and B (2)
Two milligrams of the mixture of 1 and 2 was dissolved 
in 0.5 mL of 6 mol L-1 HCl and refluxed at 105 oC for 24 h. 
Then the reaction medium was evaporated until dryness. 
The hydrolyzed product was dissolved in H2O (40 µL) and 
a 0.5 mol L-1 NaHCO3 solution was added, followed by 
80 µL of a 1.4 equiv. of Marfey’s reagent (2,4-dinitro-5-
fluoro-phenyl-l-alaninamide) in acetone. The reaction was 
stirred at 40 oC for 1 h. Afterwards, 16 µL of 0.5 mol L-1 
HCl was added to the reaction medium followed by 
evaporation to dryness. The reaction product was dissolved 
in 1 mL of MeOH. An identical derivatization procedure 
was employed for the preparation of a l-phenylalanine-
derivatized standard. The hydrolysed and the standard-
derivatized samples were analyzed by HPLC-PDA-MS 
using the following conditions: Phenomenex C18 Synergi-4 
Fusion RP-80 column, 250 × 4.6 mm; eluent: gradient of 
MeCN in Et3N/H2PO4 aqueous buffer; flow rate: 1 mL 
min-1. The hydrolyzed and derivatized sample as well 
as the derivatized phenylalanine standard were injected 
separately and co-injected. Retention time of 2,4-dinitro-
5-(l-phenylalanine)-phenyl-l-alaninamide: 14.85 min.
Antibiotic assay
Procedures for the antimicrobial assays against 
Staphylococcus aureus ATCC 6538, S. aureus ATCC 
259223, Escherichia coli ATCC861, E. coli ATCC 259222, 
Pseudomonas aeruginosa ATCC 27853, P. aeruginosa 
13, P. aeruginosa P1, Candida albicans ATCC 10231, 
C. albicans ATCC 36801 (serum type A), Enterococcus 
faecalis ATCC 14506, Streptococcus sanguinis ATCC 
15300, Streptococcus sobrinus ATCC 27607, Streptococcus 
mutans UA159, S. mutans (clinical isolate 2.M7/4) were 
performed using the broth microdilution assay, adapted 
from the National Committee for Clinical Laboratory 
Standards (USA) and from Oliveira et al.,10 as it follows. 
Briefly, bacteria were grown in BHI (Brain Heart Infusion) 
liquid medium at 37 °C and suspended, as recommended, 
to yield final inocula of approximately 106 CFU/mL. 
Tests were performed in sterile 96-well microplates by 
dispensing into each well a total volume of 100 µL (40 µL 
of medium + 20 µL de inocula + 40 µL substance solution 
diluted in H2O) and incubated 24 h at 37 oC in 10% CO2. 
Microorganism growths were determined by absorbance 
measurement at 550 nm in an automated microplate reader 
(Molecular Devices, Versa Max). The MIC was defined 
as the lowest concentration of drug that inhibited growth. 
As control microbial culture growths without the addition 
of the tested substance were used and all samples were 
assayed in replicate.
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Figure S1. 1H NMR spectrum of rodriguesines A (1) and B (2) in MeOH-d4 (400 MHz).
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Figure S2. 13C NMR spectrum of rodriguesines A (1) and B (2) in MeOH-d4 (100 MHz).
Figure S3. MS/MS analysis of rodriguesine A (1).
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Figure S4. MS/MS analysis of rodriguesine B (2).
Figure S5. 1H NMR spectrum of N-acetyl-rodriguesine A (3) in MeOH-d4 (400 MHz).
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Figure S6. 13C NMR spectrum of N-acetyl-rodriguesine A (3) in MeOH-d4 (100 MHz).
Figure S7. 1H NMR spectrum of N-acetyl-rodriguesine A (4) in MeOH-d4 (400 MHz).
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Figure S8. 13C NMR spectrum of N-acetyl-rodriguesine A (5) in MeOH-d4 (100 MHz).
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Figure S9. Marfey’s analysis of rodriguesines A (1) and B (2).
